# To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.

> **NCT01097798** · PHASE3 · UNKNOWN · sponsor: **Laboratorio Brasileiro de Biologia** · enrollment: 120 (estimated)

## Conditions studied

- Contusions
- Sprains
- Trauma
- Muscle Injury
- Myalgia
- Myofascial Pain
- Tendinitis

## Interventions

- **DRUG:** Aliviador
- **DRUG:** Gelol

## Key facts

- **NCT ID:** NCT01097798
- **Lead sponsor:** Laboratorio Brasileiro de Biologia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097798, "To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01097798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*